Newsroom

Drug for high potassium linked with increase in serious gastrointestinal injury


juin 26, 2019

Dr. Manish SoodA study led by Dr. Manish Sood found an increased rate of severe gastrointestinal injury among patients taking sodium polystyrene sulfonate (SPS) to treat high potassium levels, a symptoms of chronic kidney disease. The drug was associated with a 0.2 percent rate of gastrointestinal injury 30 days after prescribing, compared to a 0.1 percent rate among similar patients not taking the drug. While the increased risk is small (1 in 1000), the injuries, including lack of blood flow, blood clots, ulcers and perforations, can be life-threatening. This was the first study to examine SPS and gastrointestinal injury at a population level. The research team compared 20,000 SPS users with 20,000 similar non-users. They found 37 gastrointestinal injuries in SPS users versus 18 events in non-users. The findings suggest health care providers should inform patients of the risks of SPS and consider alternatives treatments for high potassium. “This study could change how physicians treat high potassium by opting for lower-risk treatments,” said Dr. Sood. 

Source: JAMA Internal Medicine

Core Resources: The Institute of Clinical Evaluative Sciences (uOttawa and Western)

Funding: Research at The Ottawa Hospital is possible because of generous donations to The Ottawa Hospital Foundation. The study was also funded by the Ontario Ministry of Health and Long-Term Care and the Canadian Institutes of Health Research

The Ottawa Hospital: Inspired by research. Driven by compassion 

The Ottawa Hospital is one of Canada’s largest learning and research hospitals with over 1,100 beds, approximately 12,000 staff and an annual budget of over $1.2 billion. Our focus on research and learning helps us develop new and innovative ways to treat patients and improve care. As a multi-campus hospital, affiliated with the University of Ottawa, we deliver specialized care to the Eastern Ontario region, but our techniques and research discoveries are adopted around the world. We engage the community at all levels to support our vision for better patient care. See www.ohri.ca for more information about research at The Ottawa Hospital.

University of Ottawa: —A crossroads of cultures and ideas

The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe. www.uottawa.ca

Media Contact

Amelia Buchanan
Senior Communication Specialist
Ottawa Hospital Research Institute
Office: 613-798-5555 x 73687
Cell: 613-297-8315
ambuchanan@ohri.ca

 

Disease and research area tags: Kidney disease, Vascular, heart and metabolic disease

Scientific Program tags: Inflammation and Chronic Disease Program